Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay K Nooka

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Glücksklee, the Quad, and High-Risk MyelomaAjay K Nooka, Jonathan L Kaufman, Sagar Lonial
Cancer|August 10, 2021
"I took the road less traveled, and that has made all the difference": Making a case for high-dose therapy and autologous stem cell transplantation in elderly patients with newly diagnosed multiple myelomaAjay K Nooka, Nisha S Joseph, Sagar Lonial
Journal of Oncology Practice|February 13, 2016
Meningeal MyelomatosisZachariah DeFilipp, Entezam A Sahovic, Ajay K Nooka
JCO Oncology Practice|February 11, 2020
Approaches to Treating Multiple Myeloma, Now and Moving ForwardVikas A Gupta, Nisha S Joseph, Ajay K Nooka
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2022
Moving Toward a Cure for MyelomaMaría-Victoria Mateos, Ajay K Nooka, Sarah M Larson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 22, 2026
Smoldering Multiple Myeloma: From Clinical to Immunogenomic Risk Stratification and Therapeutic Implications of Early InterventionNizar J Bahlis, María V Mateos, Ajay K Nooka
Blood|April 4, 2015
Treatment options for relapsed and refractory multiple myelomaAjay K Nooka, Efstathios Kastritis, Meletios A Dimopoulos, et al.
Biomed Research International|December 19, 2013
From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseasesRaghavan Chinnadurai, Edmund K Waller, Jacques Galipeau, et al.
Blood Advances|January 4, 2018
TG02 inhibits proteasome inhibitor-induced HSF1 serine 326 phosphorylation and heat shock response in multiple myelomaShardule P Shah, Ajay K Nooka, Sagar Lonial, et al.
Blood Advances|January 9, 2024
Shrinking the divide: improving myeloma CART accessAjay K Nooka, Monique A Hartley-Brown, Kenneth C Anderson, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Glücksklee, the Quad, and High-Risk MyelomaAjay K Nooka, Jonathan L Kaufman, Sagar Lonial
Cancer|August 10, 2021
"I took the road less traveled, and that has made all the difference": Making a case for high-dose therapy and autologous stem cell transplantation in elderly patients with newly diagnosed multiple myelomaAjay K Nooka, Nisha S Joseph, Sagar Lonial
Journal of Oncology Practice|February 13, 2016
Meningeal MyelomatosisZachariah DeFilipp, Entezam A Sahovic, Ajay K Nooka
JCO Oncology Practice|February 11, 2020
Approaches to Treating Multiple Myeloma, Now and Moving ForwardVikas A Gupta, Nisha S Joseph, Ajay K Nooka
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2022
Moving Toward a Cure for MyelomaMaría-Victoria Mateos, Ajay K Nooka, Sarah M Larson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 22, 2026
Smoldering Multiple Myeloma: From Clinical to Immunogenomic Risk Stratification and Therapeutic Implications of Early InterventionNizar J Bahlis, María V Mateos, Ajay K Nooka
Blood|April 4, 2015
Treatment options for relapsed and refractory multiple myelomaAjay K Nooka, Efstathios Kastritis, Meletios A Dimopoulos, et al.
Biomed Research International|December 19, 2013
From single nucleotide polymorphisms to constant immunosuppression: mesenchymal stem cell therapy for autoimmune diseasesRaghavan Chinnadurai, Edmund K Waller, Jacques Galipeau, et al.
Blood Advances|January 4, 2018
TG02 inhibits proteasome inhibitor-induced HSF1 serine 326 phosphorylation and heat shock response in multiple myelomaShardule P Shah, Ajay K Nooka, Sagar Lonial, et al.
Blood Advances|January 9, 2024
Shrinking the divide: improving myeloma CART accessAjay K Nooka, Monique A Hartley-Brown, Kenneth C Anderson, et al.
Pageof 15